SerenaPKoenigMD

Infectious Disease • Boston, MA

Associate Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School

Join to view full profile

Dr. Koenig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koenig's full profile

Already have an account?

Office
Division of Global Health Equity, Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115
Phone+1 617-732-6660

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2003 - 2006
Brigham and Women's HospitalResidency, Internal Medicine, 1995 - 1998
University of Washington School of MedicineClass of 1995

Certifications & Licensure

MA State Medical License 1997 - 2026
American Board of Internal Medicine Infectious Disease

Clinical Trials

Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care Start of enrollment: 2013 Aug 01
Unknown status
Not Applicable
A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV Start of enrollment: 2017 Nov 06
Completed
Not Applicable
Immediate Fast-Track Versus Standard Care for Persons Living With HIV in Haiti Start of enrollment: 2018 Nov 27
Completed
Not Applicable
Same-Day Treatment With Genvoya vs. EFV/TDF/3TC Start of enrollment: 2018 May 01
Withdrawn
Not Applicable
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD Start of enrollment: 2020 Sep 01
Not yet recruiting
Not Applicable
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults Start of enrollment: 2020 Sep 01
Not yet recruiting
Phase 4
Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB Start of enrollment: 2023 Nov 24
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

136 citations
Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience.
Serena P. Koenig, Fernet Leandre, Paul Farmer
AIDS. 2004-06-01
362 citations
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman, Jan-Willem C. Alffenaar, Laura F Anderson
Lancet. 2018-09-08
179 citations
Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.
Serena P. Koenig, Nancy Dorvil, Jessy G. Dévieux, Bethany Hedt-Gauthier, Cynthia Riviere
Plos Medicine. 2017-07-25

Press Mentions

Interesting and Important Studies from IAS 2021 and IDWeek That Caught My EyeOctober 31st, 2021
Update in Tuberculosis/Pulmonary Infections 2015April 19th, 2016

Grant Support

Cost-Effectiveness Of Early Vs. Delayed Antiretroviral Therapy In HaitiFogarty International Center2009–2011
Health Outcomes/Cost Of Early VS Delayed ART In HaitiFogarty International Center2004–2007